Tumor necrosis factor-α (TNF-α) is a proinflammatory pleiotropic cytokine which may contribute to the initiation and progression of ischemic stroke (IS). Thus far, numerous studies have been performed to examine the association between -238G/A (rs361525) and -308G/A (rs1800629) polymorphisms in the promoter regions of the TNF-α gene and susceptibility to IS, but results are still conflicting. The aim of this meta-analysis is to provide a relatively comprehensive account of the association between TNF-α -238G/A and -308G/A gene polymorphisms and susceptibility to IS. A literature search for eligible candidate gene studies published before April 20, 2015, was conducted in the PubMed, Medline, EMBASE and Google Scholar databases. The following combinations of main keywords were used: (‘Tumor Necrosis Factor-Alpha' or ‘TNF-α') and (‘ischemic stroke' or ‘cerebral infarction' or ‘IS') and (‘genetic polymorphism' or ‘single nucleotide polymorphisms' or ‘SNP'). Fixed- or random-effect models were used to estimate the pooled odds ratio (OR) and 95% confidence interval (CI). Meta-analysis was carried out by using RevMan 5.3 software. For TNF-α -238G/A gene polymorphism, 7 case-control studies with a total of 1,846 IS patients and 1,905 controls showed a significant association with susceptibility to IS under a dominant model (AA + GA vs. GG; OR, 1.40; 95% CI, 1.11-1.76; p value 0.004). For TNF-α -308G/A gene polymorphism, 16 case-control studies with a total of 5,651 IS patients and 5,792 controls showed a significant protective association with susceptibility to IS under a dominant model (AA + GA vs. GG; OR, 0.78, 95% CI, 0.63-0.97; p value 0.03). Our meta-analysis shows that TNF-α -238G/A gene polymorphism is more likely to be associated with the risk of IS in Caucasian populations as compared to Asian populations. However, TNF-α -308G/A gene polymorphism is more likely to be protective against IS in Asian populations as compared to Caucasian populations. Further large, well-designed prospective epidemiological studies are needed to confirm these findings.

Keywords:
Meta-analysis, Polymorphisms, Tumor necrosis factor-α, Ischemic stroke, Cytokines, Cerebral infarction, Inflammatory gene
1.
Feigin VL, Lawes CMM, Bennett DA, Barker-Collo SL, Parag V: Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009;8:355-369.
2.
Bevan S, Markus HS: Genetics of common polygenic ischaemic stroke: current understanding and future challenges. Stroke Res Treat 2011;2011:179061.
3.
Kim SK, Kang SW, Kim DH, Yun DH, Chung J-H, Ban JY: Matrix metalloproteinase-3 gene polymorphisms are associated with ischemic stroke. J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res 2012;32:81-86.
4.
Jin R, Yang G, Li G: Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 2010;87:779-789.
5.
Carr FJ, McBride MW, Carswell HVO, Graham D, Strahorn P, Clark JS, et al: Genetic aspects of stroke: human and experimental studies. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 2002;22:767-773.
6.
Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
7.
Bazzoni F, Beutler B: The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-1725.
8.
Terry CM, Clikeman JA, Hoidal JR, Callahan KS: TNF-alpha and IL-1alpha induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells. Am J Physiol 1999;276:H1493-H1501.
9.
Mark KS, Trickler WJ, Miller DW: Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells. J Pharmacol Exp Ther 2001;297:1051-1058.
10.
Hallenbeck JM: The many faces of tumor necrosis factor in stroke. Nat Med 2002;8:1363-1368.
11.
Kitagawa K, Matsumoto M, Mabuchi T, Yagita Y, Ohtsuki T, Hori M, et al: Deficiency of intercellular adhesion molecule 1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 1998;18:1336-1345.
12.
Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, et al: Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke J Cereb Circ 1997;28:1233-1244.
13.
Mekinian A, Tamouza R, Pavy S, Gestermann N, Ittah M, Mariette X, et al: Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis. Eur Cytokine Netw 2011;22:88-102.
14.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
15.
Bauer T, Bouman HJ, van Werkum JW, Ford NF, ten Berg JM, Taubert D: Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis. BMJ 2011;343:d4588.
16.
Attia J, Thakkinstian A, D'Este C: Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 2003;56:297-303.
17.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
18.
Gu L, Su L, Wu G, Chen Q, Yan Y, Xie J, et al: Association between TNF-δ 238G/A polymorphisms and the risk of ischemic stroke. Int J Neurosci 2013;123:1-6.
19.
Gu L, Wu G, Long J, Su L, Yan Y, Chen Q, et al: The role of TNF-α 308G>A polymorphism in the risk for ischemic stroke. Am J Med Sci 2013;345:227-233.
20.
Pereira TV, Rudnicki M, Franco RF, Pereira AC, Krieger JE: Effect of the G-308A polymorphism of the tumor necrosis factor alpha gene on the risk of ischemic heart disease and ischemic stroke: a meta-analysis. Am Heart J 2007;153:821-830.
21.
Lalouschek W, Schillinger M, Hsieh K, Endler G, Greisenegger S, Marculescu R, et al: Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin Chem Lab Med 2006;44:918-23.
22.
Tuttolomondo A, Di Raimondo D, Forte GI, Casuccio A, Vaccarino L, Scola L, et al: Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine 2012;58:398-405.
23.
Sultana S, Kolla VK, Jeedigunta Y, Penagaluru PK, Joshi S, Rani PU, et al: Tumour necrosis factor alpha and interleukin 10 gene polymorphisms and the risk of ischemic stroke in south Indian population. J Genet 2011;90:361-364.
24.
Banerjee I, Gupta V, Ahmed T, Faizaan M, Agarwal P, Ganesh S: Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population. Brain Res Bull 2008;75:158-65.
25.
Rubattu S, Speranza R, Ferrari M, Evangelista A, Beccia M, Stanzione R, et al: A role of TNF-alpha gene variant on juvenile ischemic stroke: a case-control study. Eur J Neurol 2005;12:989-993.
26.
Harcos P, Laki J, Kiszel P, Széplaki Z, Szolnoki Z, Kovács M, et al: Decreased frequency of the TNF2 allele of TNF-alpha -308 promoter polymorphism is associated with lacunar infarction. Cytokine 2006;33:100-105.
27.
Balding J, Livingstone WJ, Pittock SJ, Mynett-Johnson L, Ahern T, Hodgson A, et al: The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. Ir J Med Sci 2004;173:200-203.
28.
Lee B-C, Ahn S-Y, Doo H-K, Yim S-V, Lee H-J, Jin S-Y, et al: Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene. Neurosci Lett 2004;357:33-6.
29.
Um J-Y, Kim H-M: Tumor necrosis factor alpha gene polymorphism is associated with cerebral infarction. Brain Res Mol Brain Res 2004;122:99-102.
30.
Kim OJ, Lee JH, Choi JK, Oh SH, Hong SH, Oh D, et al: Association between tumor necrosis factor-alpha (-308G→A and -238G→A) polymorphisms and homocysteine levels in patients with ischemic strokes and silent brain infarctions. Cerebrovasc Dis 2010;30:483-90.
31.
Tong Y, Geng Y, Xu J, Wang Z, Zhang Y, Lin L, et al: The role of functional polymorphisms of the TNF-alpha gene promoter in the risk of ischemic stroke in Chinese Han and Uyghur populations: two case-control studies. Clin Chim Acta 2010; 411:1291-5.
32.
Wawrzynek A, Dobiała J, Wender M, Kozubski W, Michałowska-Wender G: TNFα gene G-308A polymorphism and the risk of ischemic stroke. Neurol Neurochir Pol 2014;48:387-390.
33.
Llamas Sillero P, Fernández de Velasco Casarrubios J, García-Raso A, Meseguer Gancedo E, Santos Montero AB, Tomás Martínez JF: Polymorphism -238 G/A of tumor necrosis factor alpha gene promoter is a genetic risk factor for ischemic cerebrovascular disease. J Mol Neurosci 2007; 32:108-110.
34.
Wu K, Li G-j, Wang Z: Association study of TNFα- 238 G/A polymorphisnis in senior Han patients with cerebral infarction in Haina. Chin J Geriatr Heart Brain Vessel Dis 2011;13:1011-1012.
35.
Liu Z-W, et al: Study on TNF-a 238G/A polymorphisms in patients with cerebral infarction. Anat Res 2009;31:259-262.
36.
Cui G, Wang H, Li R, Zhang L, Li Z, Wang Y, et al: Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. J Neuroinflammation 2012;9:235.
37.
Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, Nakano T, et al: A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 2007;39:212-217.
38.
Ikram MA, Seshadri S, Bis JC, Fornage M, DeStefano AL, Aulchenko YS, et al: Genomewide association studies of stroke. N Engl J Med 2009;360:1718-1728.
39.
Yamada Y, Fuku N, Tanaka M, Aoyagi Y, Sawabe M, Metoki N, et al: Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis 2009;207:144-149.
40.
International Stroke Genetics Consortium (ISGC), Wellcome Trust Case Control Consortium 2 (WTCCC2), Bellenguez C, Bevan S, Gschwendtner A, Spencer CCA, et al: Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet 2012;44:328-333.
41.
Kilarski LL, Achterberg S, Devan WJ, Traylor M, Malik R, Lindgren A, et al: Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology 2014;83:678-685.
42.
Freilinger T, Bevan S, Ripke S, Gschwendtner A, Lichtner P, Müller-Myhsok B, et al: Genetic variation in the lymphotoxin-alpha pathway and the risk of ischemic stroke in European populations. Stroke J Cereb Circ 2009;40:970-972.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.